O consumo alimentar de crianças com Transtorno do Espectro Autista está correlacionado com alterações sensório-oral e o comportamento alimentar / The food consumption of children with Autism Spectrum Disorder is correlated with sensory-oral changes and eating behavior

Objetivo: Avaliar as alterações sensoriais, o comportamento e o consumo alimentar de crianças com Transtorno do Espectro Autista. Métodos: Pesquisa transversal, quantitativa, com 30 crianças de 3 a 10 anos de idade com Transtorno do Espectro Autista. As coletas foram através de questionários, como a Escala de Avaliação do Comportamento Alimentar; Questionário de Frequência Alimentar e o Questionário de Perfil Sensorial. Os dados foram expressos em média, desvio padrão, mediana, mínimo e máximo e frequência utilizando significância de <0,05. Resultados: as maiores dificuldade no comportamento alimentar foram apresentadas pelas crianças na faixa etária ?6 anos. Em relação ao perfil sensório-oral e táctil a maioria das crianças apresentou comportamento atípico (76,7% e 86,7%, respectivamente). A preferência alimentar das crianças ?6 anos ficou pelos grupos dos alimentos não saudáveis, enquanto as >6 anos ficaram com o grupo dos alimentos saudáveis. Houve uma correlação positiva do processamento sensório-oral com o consumo de vegetais. No comportamento alimentar, a seletividade alimentar se correlacionou negativamente com o consumo de vegetais, enquanto os aspectos comportamentais se correlacionaram negativamente com o consumo de vegetais e positivamente com o consumo de doces, salgadinhos e guloseimas. Conclusões: Os resultados sugerem que os esforços para aumentar o consumo de vegetais e diminuir o consumo de guloseimas podem ser melhorados através da inclusão de estratégias que abordam o processamento sensório-oral, e os aspectos do comportamento alimentar

Pressure measures, capillary glycaemia, comorbidity and medications self-referred for elderly

Objetivo: Investigar em idosos frequentadores de um clube para a pessoa idosa de João Pessoa/PB, prevalência de comorbidade e uso de medicamentos autorreferidos, pressão arterial e glicemia capilar, como fatores de risco que contribuem para o aparecimento de doenças cardiovasculares. Métodos: Estudo realizado com 84 idosos, utilizando um questionário composto de duas partes: perguntas abertas sobre variáveis sociodemográficas, comorbidades e medicamentos autorreferidos; e verificação da pressão arterial e glicemia capilar. A análise foi realizada pelo programa SPSS 19.0. Resultados: Observou-se alta prevalência de idosos com hipertensão e diabetes autorreferida e que o maior número de medicamentos utilizados são aqueles voltados para o sistema cardiovascular. Destaca-se parcela do grupo estudado com taxas de glicemia e pressão arterial elevada, mas desconhecem-na. Conclusão: Os dados reforçam a necessidade de fiscalização e controle, racionalização, conscientização e humanização por parte de gestores e profissionais que atuam com idosos. Descritores: Idoso, Medicamentos, Morbidade

Pressure measures, capillary glycaemia, comorbidity and medications self-referred for elderly

Objetivo: Investigar em idosos frequentadores de um clube para a pessoa idosa de João Pessoa/PB, prevalência de comorbidade e uso de medicamentos autorreferidos, pressão arterial e glicemia capilar, como fatores de risco que contribuem para o aparecimento de doenças cardiovasculares. Métodos: Estudo realizado com 84 idosos, utilizando um questionário composto de duas partes: perguntas abertas sobre variáveis sociodemográficas, comorbidades e medicamentos autorreferidos; e verificação da pressão arterial e glicemia capilar. A análise foi realizada pelo programa SPSS 19.0. Resultados: Observou-se alta prevalência de idosos com hipertensão e diabetes autorreferida e que o maior número de medicamentos utilizados são aqueles voltados para o sistema cardiovascular. Destaca-se parcela do grupo estudado com taxas de glicemia e pressão arterial elevada, mas desconhecem-na. Conclusão: Os dados reforçam a necessidade de fiscalização e controle, racionalização, conscientização e humanização por parte de gestores e profissionais que atuam com idosos. Descritores: Idoso, Medicamentos, Morbidade

Effects of antiplatelet therapy on stroke risk by brain imaging features of intracerebral haemorrhage and cerebral small vessel diseases: subgroup analyses of the RESTART randomised, open-label trial

Background Findings from the RESTART trial suggest that starting antiplatelet therapy might reduce the risk of recurrent symptomatic intracerebral haemorrhage compared with avoiding antiplatelet therapy. Brain imaging features of intracerebral haemorrhage and cerebral small vessel diseases (such as cerebral microbleeds) are associated with greater risks of recurrent intracerebral haemorrhage. We did subgroup analyses of the RESTART trial to explore whether these brain imaging features modify the effects of antiplatelet therapy

Emergências hiperglicêmicas e seus impactos na sala de emergência: uma revisão de literatura / Hyperglycemic emergencies and their impacts in the emergency room: a literature review

Introdução: Hiperglicemia é uma causa muito comum nas emergências médicas, sendo uma alteração de descompensação do metabolismo. Os estados hiperglicêmicos agudos compreendem a cetoacidose diabética e o coma hiperosmolar hiperglicêmico não cetótico. Objetivo: Analisar as duas principais condições hiperglicêmicas, que representam um desafio para o clínico e o médico generalista em salas de emergências. Métodos: Trata-se de uma revisão integrativa da literatura que incluiu estudos, com dados de pacientes em situação de emergência hiperglicêmica, publicados entre 2010 e 2020, disponíveis na íntegra em inglês, em espanhol ou em português, na base de dados LILACS, SciELO, PubMed, com os termos: “Hiperglicemia”, “Emergência”, “Departamento/Sala de emergência”, “Crise hiperglicêmica” e “Impactos”. Atenderam aos critérios de inclusão 19 artigos, os quais, após a leitura na íntegra, tiveram as informações sintetizadas, agrupadas por semelhanças ao tema e analisadas de forma descritiva. Resultados e discussão:  Crises hiperglicêmicas podem ocorrer em pacientes portadores de diabetes mellitus tipo 1 ou tipo 2, assim, requer manejo rápido e tratamento da causa base, visando evitar a mortalidade.

Os impactos do iam para o sistema único de saúde e para o Brasil / The impacts of iam for the unique health system and for Brazil

A partir da década de 1960 vem ocorrendo diminuição das doenças infecto-parasitárias (DIP) e aumento das Doenças Crônicas Não Transmissíveis (DCNT). O Infarto Agudo do Miocárdio (IAM) é a principal causa das Doenças Cardiovasculares (DCV). Dados do Departamento de Informática do Sistema Único de Saúde (DATASUS) de 2013 revelavam que o IAM foi a principal causa de morte por doença cardíaca no Brasil e os especialistas projetam que assim seja nos próximos anos caso medidas não sejam instituídas visando inverter essa curva. Dessa forma, é de importância obter atendimento pré-hospitalar rápido e eficiente reduzindo o tempo entre o início do evento isquêmico e necrose até o tratamento. Por isso, o objetivo deste trabalho é interpretar a prevalência do IAM em relação a regiões, sexo e idade no Brasil e o possível impacto disso nos custos pro sistema único de saúde (SUS). A metodologia utilizada foi uma revisão sistemática da literatura, usando como base de dados Pubmed, Scielo e Google Acadêmico a partir das seguintes palavras-chaves: “IAM”. “incidência” e “prevalência”.

Height and body-mass index trajectories of school-aged children and adolescents from 1985 to 2019 in 200 countries and territories: a pooled analysis of 2181 population-based studies with 65 million participants

Summary Background Comparable global data on health and nutrition of school-aged children and adolescents are scarce. We aimed to estimate age trajectories and time trends in mean height and mean body-mass index (BMI), which measures weight gain beyond what is expected from height gain, for school-aged children and adolescents. Methods For this pooled analysis, we used a database of cardiometabolic risk factors collated by the Non-Communicable Disease Risk Factor Collaboration. We applied a Bayesian hierarchical model to estimate trends from 1985 to 2019 in mean height and mean BMI in 1-year age groups for ages 5–19 years. The model allowed for non-linear changes over time in mean height and mean BMI and for non-linear changes with age of children and adolescents, including periods of rapid growth during adolescence. Findings We pooled data from 2181 population-based studies, with measurements of height and weight in 65 million participants in 200 countries and territories. In 2019, we estimated a difference of 20 cm or higher in mean height of 19-year-old adolescents between countries with the tallest populations (the Netherlands, Montenegro, Estonia, and Bosnia and Herzegovina for boys; and the Netherlands, Montenegro, Denmark, and Iceland for girls) and those with the shortest populations (Timor-Leste, Laos, Solomon Islands, and Papua New Guinea for boys; and Guatemala, Bangladesh, Nepal, and Timor-Leste for girls). In the same year, the difference between the highest mean BMI (in Pacific island countries, Kuwait, Bahrain, The Bahamas, Chile, the USA, and New Zealand for both boys and girls and in South Africa for girls) and lowest mean BMI (in India, Bangladesh, Timor-Leste, Ethiopia, and Chad for boys and girls; and in Japan and Romania for girls) was approximately 9–10 kg/m2. In some countries, children aged 5 years started with healthier height or BMI than the global median and, in some cases, as healthy as the best performing countries, but they became progressively less healthy compared with their comparators as they grew older by not growing as tall (eg, boys in Austria and Barbados, and girls in Belgium and Puerto Rico) or gaining too much weight for their height (eg, girls and boys in Kuwait, Bahrain, Fiji, Jamaica, and Mexico; and girls in South Africa and New Zealand). In other countries, growing children overtook the height of their comparators (eg, Latvia, Czech Republic, Morocco, and Iran) or curbed their weight gain (eg, Italy, France, and Croatia) in late childhood and adolescence. When changes in both height and BMI were considered, girls in South Korea, Vietnam, Saudi Arabia, Turkey, and some central Asian countries (eg, Armenia and Azerbaijan), and boys in central and western Europe (eg, Portugal, Denmark, Poland, and Montenegro) had the healthiest changes in anthropometric status over the past 3·5 decades because, compared with children and adolescents in other countries, they had a much larger gain in height than they did in BMI. The unhealthiest changes—gaining too little height, too much weight for their height compared with children in other countries, or both—occurred in many countries in sub-Saharan Africa, New Zealand, and the USA for boys and girls; in Malaysia and some Pacific island nations for boys; and in Mexico for girls. Interpretation The height and BMI trajectories over age and time of school-aged children and adolescents are highly variable across countries, which indicates heterogeneous nutritional quality and lifelong health advantages and risks

Global variation in diabetes diagnosis and prevalence based on fasting glucose and hemoglobin A1c

Fasting plasma glucose (FPG) and hemoglobin A1c (HbA1c) are both used to diagnose diabetes, but these measurements can identify different people as having diabetes. We used data from 117 population-based studies and quantified, in different world regions, the prevalence of diagnosed diabetes, and whether those who were previously undiagnosed and detected as having diabetes in survey screening, had elevated FPG, HbA1c or both. We developed prediction equations for estimating the probability that a person without previously diagnosed diabetes, and at a specific level of FPG, had elevated HbA1c, and vice versa. The age-standardized proportion of diabetes that was previously undiagnosed and detected in survey screening ranged from 30% in the high-income western region to 66% in south Asia. Among those with screen-detected diabetes with either test, the age-standardized proportion who had elevated levels of both FPG and HbA1c was 29-39% across regions; the remainder had discordant elevation of FPG or HbA1c. In most low- and middle-income regions, isolated elevated HbA1c was more common than isolated elevated FPG. In these regions, the use of FPG alone may delay diabetes diagnosis and underestimate diabetes prevalence. Our prediction equations help allocate finite resources for measuring HbA1c to reduce the global shortfall in diabetes diagnosis and surveillance

Worldwide trends in underweight and obesity from 1990 to 2022: a pooled analysis of 3663 population-representative studies with 222 million children, adolescents, and adults

Background Underweight and obesity are associated with adverse health outcomes throughout the life course. We estimated the individual and combined prevalence of underweight or thinness and obesity, and their changes, from 1990 to 2022 for adults and school-aged children and adolescents in 200 countries and territories. Methods We used data from 3663 population-based studies with 222 million participants that measured height and weight in representative samples of the general population. We used a Bayesian hierarchical model to estimate trends in the prevalence of different BMI categories, separately for adults (age ≥20 years) and school-aged children and adolescents (age 5–19 years), from 1990 to 2022 for 200 countries and territories. For adults, we report the individual and combined prevalence of underweight (BMI <18·5 kg/m2) and obesity (BMI ≥30 kg/m2). For schoolaged children and adolescents, we report thinness (BMI <2 SD below the median of the WHO growth reference) and obesity (BMI >2 SD above the median). Findings From 1990 to 2022, the combined prevalence of underweight and obesity in adults decreased in 11 countries (6%) for women and 17 (9%) for men with a posterior probability of at least 0·80 that the observed changes were true decreases. The combined prevalence increased in 162 countries (81%) for women and 140 countries (70%) for men with a posterior probability of at least 0·80. In 2022, the combined prevalence of underweight and obesity was highest in island nations in the Caribbean and Polynesia and Micronesia, and countries in the Middle East and north Africa. Obesity prevalence was higher than underweight with posterior probability of at least 0·80 in 177 countries (89%) for women and 145 (73%) for men in 2022, whereas the converse was true in 16 countries (8%) for women, and 39 (20%) for men. From 1990 to 2022, the combined prevalence of thinness and obesity decreased among girls in five countries (3%) and among boys in 15 countries (8%) with a posterior probability of at least 0·80, and increased among girls in 140 countries (70%) and boys in 137 countries (69%) with a posterior probability of at least 0·80. The countries with highest combined prevalence of thinness and obesity in school-aged children and adolescents in 2022 were in Polynesia and Micronesia and the Caribbean for both sexes, and Chile and Qatar for boys. Combined prevalence was also high in some countries in south Asia, such as India and Pakistan, where thinness remained prevalent despite having declined. In 2022, obesity in school-aged children and adolescents was more prevalent than thinness with a posterior probability of at least 0·80 among girls in 133 countries (67%) and boys in 125 countries (63%), whereas the converse was true in 35 countries (18%) and 42 countries (21%), respectively. In almost all countries for both adults and school-aged children and adolescents, the increases in double burden were driven by increases in obesity, and decreases in double burden by declining underweight or thinness. Interpretation The combined burden of underweight and obesity has increased in most countries, driven by an increase in obesity, while underweight and thinness remain prevalent in south Asia and parts of Africa. A healthy nutrition transition that enhances access to nutritious foods is needed to address the remaining burden of underweight while curbing and reversing the increase in obesit

Global variations in diabetes mellitus based on fasting glucose and haemogloblin A1c

Fasting plasma glucose (FPG) and haemoglobin A1c (HbA1c) are both used to diagnose diabetes, but may identify different people as having diabetes. We used data from 117 population-based studies and quantified, in different world regions, the prevalence of diagnosed diabetes, and whether those who were previously undiagnosed and detected as having diabetes in survey screening had elevated FPG, HbA1c, or both. We developed prediction equations for estimating the probability that a person without previously diagnosed diabetes, and at a specific level of FPG, had elevated HbA1c, and vice versa. The age-standardised proportion of diabetes that was previously undiagnosed, and detected in survey screening, ranged from 30% in the high-income western region to 66% in south Asia. Among those with screen-detected diabetes with either test, the agestandardised proportion who had elevated levels of both FPG and HbA1c was 29-39% across regions; the remainder had discordant elevation of FPG or HbA1c. In most low- and middle-income regions, isolated elevated HbA1c more common than isolated elevated FPG. In these regions, the use of FPG alone may delay diabetes diagnosis and underestimate diabetes prevalence. Our prediction equations help allocate finite resources for measuring HbA1c to reduce the global gap in diabetes diagnosis and surveillance.peer-reviewe